Sandoz Looks To Build U.S. Injectables Business Through Sabex Acquisition

The company will add Infufer and hydromorphone injectables in the U.S. following $565 mil. transaction. Sabex makes 89 generic molecules for the Canadian market in its FDA-approved facilities.